A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT04075916
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 201 participants
- Sponsor
- Registry
-
NCT04075916
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04075916. Allocation not applicable; no masking; primary purpose treatment. Start 2021-06-22 (actual); primary completion 2025-07-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
- Acronym
- THINKER-NEXT
- Condition
- End Stage Renal Disease
- Intervention (Drug)
- Epclusa
- Lead sponsor
- University of Pennsylvania
- Collaborator
- Gilead Sciences
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct04075916- Content hash
32d7c0edf0f1277459c3f9796ea959d6ad784c0c3f2c561794e66c177206cac1